Introduction:Basic information about CAS 5854-93-3|Alanosine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Alanosine |
|---|
| CAS Number | 5854-93-3 | Molecular Weight | 149.105 |
|---|
| Density | 1.8±0.1 g/cm3 | Boiling Point | 366.9±52.0 °C at 760 mmHg |
|---|
| Molecular Formula | C3H7N3O4 | Melting Point | 190ºC (dec.) |
|---|
| MSDS | / | Flash Point | 175.7±30.7 °C |
|---|
Names
| Name | L-Alanine,3-(hydroxynitrosoamino) |
|---|
| Synonym | More Synonyms |
|---|
Alanosine BiologicalActivity
| Description | L-Alanosine (NSC-153353), an antibiotic from Streptomyces alanosinicus, has antineoplastic activity. L-Alanosine (NSC-153353) inhibits adenylosuccinate synthetase, which converts inosine monophospate (IMP) into adenylosuccinate. L-Alanosine (NSC-153353) blocks the common de novo purine biosynthesis pathway and, thereby, inhibits tumor cells with MTAP deficiency[1][2][3]. |
|---|
| Related Catalog | Research Areas >>CancerResearch Areas >>InfectionSignaling Pathways >>Others >>Others |
|---|
| References | [1]. Efferth T, et al. Identification of gene expression profiles predicting tumor cell response to L-alanosine. Biochem Pharmacol. 2003 Aug 15;66(4):613-21. [2]. Chitnis MP, et al. Antitumor effect of L-alanosine (NSC 153553) on sensitive and resistant sublines of murine leukemias. Tumori. 1984 Aug 31;70(4):317-20. [3]. Tyagi AK, et al. Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase. Cancer Res. 1980 Dec;40(12):4390-7. |
|---|
Chemical & Physical Properties
| Density | 1.8±0.1 g/cm3 |
|---|
| Boiling Point | 366.9±52.0 °C at 760 mmHg |
|---|
| Melting Point | 190ºC (dec.) |
|---|
| Molecular Formula | C3H7N3O4 |
|---|
| Molecular Weight | 149.105 |
|---|
| Flash Point | 175.7±30.7 °C |
|---|
| Exact Mass | 149.043655 |
|---|
| PSA | 116.22000 |
|---|
| LogP | -0.56 |
|---|
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
|---|
| Index of Refraction | 1.616 |
|---|
| InChIKey | ZGNLFUXWZJGETL-UHFFFAOYSA-N |
|---|
| SMILES | NC(C[N+]([O-])=NO)C(=O)O |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- UE6490000
- CHEMICAL NAME :
- Propionic acid, 2-amino-3-(hydroxynitrosamino)-, (L)-
- CAS REGISTRY NUMBER :
- 5854-93-3
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 3
- MOLECULAR FORMULA :
- C3-H7-N3-O4
- MOLECULAR WEIGHT :
- 149.13
- WISWESSER LINE NOTATION :
- QVYZ1NQNO -L
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 600 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #3676490
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 845 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 300 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #3676490
|
Synonyms
| SDX-102 |
| L-Alanine, 3-(hydroxynitrosoamino)- |
| L-2-Amino-3-[(N-nitroso)hydroxylamino]propionic acid |
| alanosine |
| L-2-Amino-3-(hydroxynitrosoamino)propanoic Acid |
| 3-[Hydroxy(nitroso)amino]-L-alanine |
| SDX 102 |
| L-alanosine |
| L-Alanine, 3- (hydroxynitrosoamino)- |